SynthesisInternational journal for equity in health2023
Characterization of the population affiliated to the subsidized health insurance scheme in Colombia: a systematic review and meta-analysis.
Synthesis in International journal for equity in health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Health insurance expansion for migrants and maternal, perinatal, and infant health outcomes in Colombia: a national cohort study (2013-2020).Lancet regional health. Americas · 2026Article
- Patterns of sex differences in cancer mortality in Colombia: a population-based analysis, 1980-2023.Lancet regional health. Americas · 2026Article
- Treatment patterns and outcomes in patients with multiple myeloma in second relapse in Colombia (freedomm): a multicenter observational study.Frontiers in oncology · 2026Article
- Factors Associated With Severe Dengue During the 2019 Outbreak in Southern Colombia: Implications for Hyperendemic Regions.Journal of tropical medicine · 2026Article
- Differences between male and female mortality in Colombia: a population-based analysis since 1980.Lancet regional health. Americas · 2025Article
- Expenditure and use on radiology imaging in urban and rural areas in a developing country.Cost effectiveness and resource allocation : C/E · 2025Article
- Lorenz curves of urban and rural health care expenditure in Colombia: analysis of a cohort of 4.6 million patients.Health economics review · 2025Article
- Analysis of Maternity Rights Perception: Impact of Maternal Care in Diverse Socio-Health Contexts.European journal of investigation in health, psychology and education · 2025Article
- Health for all? A cost-utility evaluation of Colombia's policy to enroll Venezuelan migrants (2021-2023).Journal of migration and health · 2025Article
- Identification of population multimorbidity patterns in 3.9 million patients from Bogota in 2018.Global epidemiology · 2024Article
- Study on the concentration, distribution, and persistence of health spending for the contributory scheme in Colombia.BMC health services research · 2024Article
- Telerehabilitation in Colombia: A Country Report and Qualitative Analysis During the Covid-19 Pandemic - Perceptions of Healthcare Providers and Patients.International journal of telerehabilitation · 2024Article
- Barriers in Access to Idarucizumab in Ischemic Stroke in a Middle-Income Country.The Neurohospitalist · 2024Article
- Inequalities in health system coverage and quality: a cross-sectional survey of four Latin American countries.The Lancet. Global health · 2024Review
- Loss ratio of the capitation payment unit of the health-promoting entities in Colombia between 2017 and 2021: a financial-actuarial approach.Cost effectiveness and resource allocation : C/E · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSome reports suggest there are differences in health needs between the population affiliated to the subsidized health insurance scheme (SS) and those affiliated to the contributory health insurance scheme (CS) in Colombia. The objective of this study was to identify the epidemiological profile of the population affiliated to the SS in Colombia and to compare the main epidemiological features of the SS to the CS.
methodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) methodology, the search was carried out from 1993, with no other restriction. The information was synthesized into five categories according to the most important risk populations. We estimated combined incidences from epidemiological surveillance data, prevalence ratio, and other measures to estimate the difference between the studied groups. A 95% confidence interval was considered. A random effects model was used weighted by the inverse of the variance of the cumulative incidence calculated for each disease. The risk of bias was assessed using the Joanna Briggs Institute's critical appraisal tools.
resultsA total of 16,236 articles were identified; 14,972 were excluded after title and abstract screening, 725 articles were verified as full text, and finally 268 articles were included. The relative risk of non-communicable and communicable diseases was lower in the SS than in the CS (RR: 0.37 and 0.72, respectively, p-value < 0.05). However, the risk of presenting obstetric and maternal conditions in the SS versus the CS was RR 1.55 for frequent conditions during early childhood, and for other diseases it was RR 1.28 with a p-value of < 0.05. The use of health services was different by scheme, with less demand, access, and provision being found in health services in the SS.
conclusionsThis study allowed us to conclude that there are differences in the incidence, prevalence, and use of health services between health affiliation schemes (SS and CS) in Colombia, thereby assisting in decision-making for stakeholders.
trial registrationPROSPERO Registration number CRD42021279234.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.